There’s growing evidence the B.1.1.7 variant was formed inside the body of an immunocompromised COVID-19 patient. Farah Nasser explains how, and how COVID-19 vaccines impact different variants and patients.
Global National
Viral evolution in immunocompromised COVID-19 patients
More Videos
-
Sweet dreams: How Manitoba could boost Canada’s maple syrup industry
-
Foreign interference bill welcomed but needs work, diaspora groups say
-
Gaza crisis: Israel seizes Rafah crossing, launches assault
-
Nijjar murder: Top Indian diplomat worries about Sikh activists in Canada
-
Trump trial: Stormy Daniels’ graphic testimony at hush money trial
-
Police investigate shooting at Drake’s Toronto mansion amid rapper’s beef with Kendrick Lamar
You are viewing an Accelerated Mobile Webpage.
View Original Article